press release details

Press Releases

Lam Research Corporation Reports Financial Results for the Quarter Ended December 28, 2014

View PDF

FREMONT, CA -- (Marketwired) -- 01/28/15 -- Lam Research Corp.(NASDAQ: LRCX) today announced financial results for the quarter ended December 28, 2014 (the "December 2014 quarter").

Highlights for the December 2014 quarter were as follows:

  • Shipments of $1,247 million, up 12% from the prior quarter.
  • Revenue of $1,232 million, up 7% from the prior quarter.
  • GAAP gross margin of 43.6%, GAAP operating margin of 15.3% and GAAP diluted EPS of $1.00
  • Non-GAAP gross margin of 45.4%, non-GAAP operating margin of 18.7%, and non-GAAP diluted EPS of $1.19
 
Lam Research Corporation 
Financial Highlights for the Quarters Ended December 28, 2014 and September 28, 2014 
(in thousands, except per share data and percentages) 
        
GAAP
  December 2014  September 2014 Change Q/Q
        
Revenue$1,232,241 $1,152,368 7%
Gross margin as percentage of revenue 43.6%  43.9% -30 bps
Operating margin as percentage of revenue 15.3%  14.6% 70 bps
Diluted EPS$1.00 $0.80 25%
        
Non-GAAP
  December 2014  September 2014 Change Q/Q
        
Revenue$1,232,241 $1,152,368 7%
Gross margin as percentage of revenue 45.4%  45.8% -40 bps
Operating margin as percentage of revenue 18.7%  18.0% 70 bps
Diluted EPS$1.19 $0.96 24%
        
 

GAAP Financial Results

For the December 2014 quarter, revenue was $1,232.2 million, gross margin was $536.7 million, or 43.6% of revenue, operating expenses were $347.9 million, operating margin was 15.3% of revenue, and net income was $176.9 million, or $1.00 per diluted share on a GAAP basis. This compares to revenue of $1,152.4 million, gross margin of $505.5 million, or 43.9% of revenue, operating expenses of $337.2 million, operating margin of 14.6% of revenue, and net income of $141.1 million, or $0.80 per diluted share, for the quarter ended September 28, 2014 (the "September 2014 quarter").

Non-GAAP Financial Results

For the December 2014 quarter, non-GAAP gross margin was $560.0 million or 45.4% of revenue, non-GAAP operating expenses were $330.2 million, non-GAAP operating margin was 18.7% of revenue, and non-GAAP net income was $207.6 million, or $1.19 per diluted share. This compares to non-GAAP gross margin of $528.0 million or 45.8% of revenue, non-GAAP operating expenses of $321.2 million, non-GAAP operating margin of 18.0% of revenue, and non-GAAP net income of $167.7 million, or $0.96 per diluted share for the September 2014 quarter.

"Lam's December quarter concludes a record calendar year for the Company defined by outperformance in our industry and strong execution on our priorities," said Martin Anstice, Lam Research's president and chief executive officer. "For the year we grew revenue at twice the rate of the industry and made good progress on our market share objectives. Our strong execution combined with a meaningful market expansion is enabling a compelling multi-year growth opportunity." 

Balance Sheet and Cash Flow Results

Cash and cash equivalents, short-term investments, and restricted cash and investment balances remained steady at $3.0 billion at the end of both the December 2014 quarter and the September 2014 quarter. Cash provided by operating activities was utilized for approximately $65.5 million of treasury stock purchases including net share settlement on employee stock-based compensation, $61.4 million of capital expenditures and $29.4 million of cash dividends paid to stockholders during the December 2014 quarter.

Deferred revenue at the end of the December 2014 quarter increased to $373.7 million as compared to $356.8 million at the end of the September 2014 quarter. Deferred profit at the end of the December 2014 quarter increased to $254.8 million as compared to $251.8 million at the end of the September 2014 quarter. Lam's deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The anticipated future revenue from shipments to Japanese customers was approximately $53.2 million as of December 28, 2014.

Geographic Distribution

The geographic distribution of shipments and revenue during the December 2014 quarter is shown in the following table:

   
RegionShipmentsRevenue
Taiwan23%25%
Korea30%24%
United States16%18%
Japan13%12%
China7%8%
Southeast Asia4%7%
Europe7%6%
   
 

Outlook

For the quarter ending March 29, 2015, Lam is providing the following guidance:

      
 GAAP Reconciling
Items
 Non-GAAP
Shipments$1.45 Billion+/-$50 Million - $1.45 Billion+/-$50 Million
Revenue$1.37 Billion+/-$50 Million - $1.37 Billion+/-$50 Million
Gross margin42.5%+/-1% $21 Million 44.0%+/-1%
Operating margin16.3%+/-1% $37 Million 19.0%+/-1%
Earnings per share$1.06+/-$0.07 $38 Million $1.30+/-$0.07
Diluted share count177 Million 3 Million 174 Million
      
 

The information provided above is only an estimate of what the Company believes is realizable as of the date of this release, and does not incorporate the potential impact of any business combinations, asset acquisitions, divestitures, financing arrangements, other investments, or other significant transactions that may be completed after the date of this release. GAAP to non-GAAP reconciling items provided include only those items that are known and can be estimated as of the date of this release. Actual results will vary from this model and the variations may be material. Reconciling items included above are as follows:

  • Gross margin -- amortization related to intangible assets acquired in the Novellus transaction, $21 million.
  • Operating margin -- amortization related to intangible assets acquired in the Novellus transaction, $37 million.
  • Earnings per share -- amortization related to intangible assets acquired in the Novellus transaction, $37 million; amortization of convertible note discounts, $8 million; and associated tax benefit for non-GAAP items ($7) million; totaling $38 million.
  • Diluted share count -- impact of a note hedge issued contemporaneously with the convertible notes due in 2016 and 2018, 3 million shares.

Use of Non-GAAP Financial Results

In addition to GAAP results, this press release also contains non-GAAP financial results. The Company's non-GAAP results for both the December 2014 and September 2014 quarters include the impact of the note hedge issued contemporaneously with the convertible notes due in 2016 and 2018 and exclude amortization related to intangible assets acquired in the Novellus transaction, the amortization of convertible note discounts, and tax expense (benefit) of non-GAAP items. Additionally, the December 2014 quarter non-GAAP results exclude acquisition-related inventory fair value adjustments, cost of restructuring and tax benefit on reinstatement of research and development credit. The September 2014 quarter non-GAAP results also exclude the rationalization of certain product configurations, gain associated with disposition of a business, and tax benefit on valuation allowance adjustment.

Management uses non-GAAP gross margin, operating income, operating expenses, operating margin, net income, and net income per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of non-GAAP results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing investors' ability to view the Company's results from management's perspective. Tables presenting reconciliations of non-GAAP results to GAAP results are included at the end of this press release and on the Company's web site at http://investor.lamresearch.com.

Caution Regarding Forward-Looking Statements

Statements made in this press release that are not of historical fact are forward-looking statements and are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate to, but are not limited to, the anticipated revenue from shipments to Japanese customers; our ability to continue to outperform the semiconductor equipment industry; our ability to continue to grow our revenue and make progress on our market share objectives; our ability to execute and deliver performance that meets or exceeds our plans, including our abilities to execute on our priorities, and deliver multi-year growth; the scope of opportunities we have; our ability to expand our served market; the ability of the market to continue to expand and the extent of any such expansion; and our guidance for shipments, revenue, gross margin, operating margin, earnings per share, and diluted share count. Some factors that may affect these forward-looking statements include: business conditions in the consumer electronics industry, the semiconductor industry and the overall economy; the strength of the financial performance of our existing and prospective customers; the introduction of new and innovative technologies; the occurrence and pace of technology transitions and conversions; the actions of our competitors, consumers, semiconductor companies and key suppliers and subcontractors; and the success of research and development and sales and marketing programs. These forward-looking statements are based on current expectations and are subject to uncertainties and changes in condition, significance, value and effect as well as other risks, including those detailed in documents filed by us with the Securities and Exchange Commission, including specifically our report on Form 10-K for the year ended June 29, 2014 and the Form 10-Q for the quarter ended September 28, 2014. These uncertainties and changes could cause actual results to vary from expectations. The Company undertakes no obligation to update the information or statements made in this press release.

About Lam Research

Lam Research Corp.(NASDAQ: LRCX) is a trusted global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. Lam's broad portfolio of market-leading deposition, etch, strip, and wafer cleaning solutions helps customers achieve success on the wafer by enabling device features that are 1,000 times smaller than a grain of sand, resulting in smaller, faster, and more power-efficient chips. Through collaboration, continuous innovation, and delivering on commitments, Lam is transforming atomic-scale engineering and enabling its customers to shape the future of technology. Based in Fremont, Calif., Lam Research is a NASDAQ-100 Index® and S&P 500® company whose common stock trades on the NASDAQ® Global Select Market™ under the symbol LRCX. For more information, please visit http://www.lamresearch.com. (LRCX-F)

Consolidated Financial Tables Follow.

  
LAM RESEARCH CORPORATION 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 
(in thousands, except per share data and percentages) 
(unaudited) 
            
  Three Months Ended Six Months Ended 
 
 
 
 
December 28,  2014 
 
September 28,  2014 
 
December 29,  2013 
 
December 28,  2014 
 
December 29,  2013 
 
Revenue $1,232,241 $1,152,368 $1,116,061 $2,384,609 $2,131,120 
 Cost of goods sold  695,584  646,829  628,272  1,342,413  1,211,473 
  Gross margin  536,657  505,539  487,789  1,042,196  919,647 
  Gross margin as a percent of revenue  43.6%  43.9%  43.7%  43.7%  43.2% 
Research and development  196,768  188,934  174,477  385,702  345,044 
Selling, general and administrative  151,148  148,307  148,838  299,455  304,721 
  Total operating expenses  347,916  337,241  323,315  685,157  649,765 
  Operating income  188,741  168,298  164,474  357,039  269,882 
  Operating margin as a percent of revenue  15.3%  14.6%  14.7%  15.0%  12.7% 
Other expense, net  (9,799) (5,648) (3,837) (15,447) (18,099)
  Income before income taxes  178,942  162,650  160,637  341,592  251,783 
Income tax expense  2,002  21,569  11,645  23,571  17,285 
  Net income $176,940 $141,081 $148,992 $318,021 $234,498 
Net income per share:                
 Basic net income per share $1.11 $0.87 $0.92 $1.98 $1.44 
 Diluted net income per share $1.00 $0.80 $0.87 $1.80 $1.37 
Number of shares used in per share calculations:                
 Basic  159,248  161,685  162,305  160,467  162,603 
 Diluted  177,046  177,118  171,757  177,082  171,592 
                 
Cash dividend declared per share $0.18 $0.18 $- $0.36 $- 
                 
 

 

 
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
          
  December 28, September 28, June 29,
  2014 2014 2014
  (unaudited) (unaudited) (1)
ASSETS         
Cash and cash equivalents $981,275 $1,293,678 $1,452,677
Short-term investments  1,902,402  1,593,668  1,612,967
Accounts receivable, net  944,014  864,403  800,616
Inventories  913,390  815,612  740,503
Other current assets  173,731  123,615  176,899
 Total current assets  4,914,812  4,690,976  4,783,662
Property and equipment, net  585,372  555,658  543,496
Restricted cash and investments  155,455  149,483  146,492
Goodwill and intangible assets  2,282,006  2,322,153  2,360,303
Other assets  173,044  175,558  159,353
 Total assets $8,110,689 $7,893,828 $7,993,306
          
LIABILITIES AND STOCKHOLDERS' EQUITY         
Current liabilities $1,708,656 $1,599,625 $1,582,001
          
Long-term debt, convertible notes, and capital leases $830,880 $824,269 $817,202
Income taxes payable  205,535  217,118  258,357
Other long-term liabilities  183,678  179,711  122,662
 Total liabilities  2,928,749  2,820,723  2,780,222
          
Senior convertible notes  181,505  182,432  183,349
Stockholders' equity (2)  5,000,435  4,890,673  5,029,735
 Total liabilities and stockholders' equity $8,110,689 $7,893,828 $7,993,306
          
 
(1) Derived from audited financial statements
 
(2) Common shares issued and outstanding were 159,294 shares as of December 28, 2014, 159,384 shares as of September 28, 2014 and 162,350 shares as of June 29, 2014.
 

 

  
LAM RESEARCH CORPORATION 
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 
(in thousands) 
(unaudited) 
                    
 Three Months Ended  Six Months Ended 
 
 
 
 
December 28, 2014 
 
 
 
September 28,  2014 
 
 
 
December 29,  2013 
 
 
 
December 28,  2014 
 
 
 
December 29,  2013 
 
CASH FLOWS FROM OPERATING ACTIVITIES:                   
Net income$176,940  $141,081  $148,992  $318,021  $234,498 
Adjustments to reconcile net income to net cash provided by operating activities:                   
 Depreciation and amortization 69,536   67,885   73,552   137,421   147,883 
 Deferred income taxes 3,320   3,186   12,457   6,506   12,457 
 Impairment of long-lived asset -   -   628   -   7,632 
 Equity-based compensation expense 30,632   32,040   23,046   62,672   46,281 
 Income tax benefit on equity-based compensation plans 1,141   9,861   -   11,002   - 
 Excess tax benefit on equity-based compensation plans (599)  (10,404)  -   (11,003)  - 
 Amortization of convertible note discount 8,609   8,509   8,217   17,118   16,339 
 Gain on sale of business -   (7,431)  -   (7,431)  - 
 Other, net 1,607   5,526   (2,428)  7,133   1,687 
 Changes in operating assets and liabilities: (129,947)  (109,092)  (135,441)  (239,039)  (285,829)
  Net cash provided by operating activities 161,239   141,161   129,023   302,400   180,948 
                    
CASH FLOWS FROM INVESTING ACTIVITIES:                   
Capital expenditures and intangible assets (61,363)  (41,871)  (38,323)  (103,234)  (62,101)
Cash paid for business acquisition -   (1,137)  (18,388)  (1,137)  (18,388)
Net sales/maturities (purchases) of available-for-sale securities (321,590)  9,645   (88,754)  (311,945)  (46,187)
Repayment of notes receivable 3,978   -   10,000   3,978   10,000 
Proceeds from sale of business, net -   41,212   -   41,212   - 
Proceeds from sale of assets -   -   21,635   -   21,635 
Transfer of restricted cash and investments 100   22   -   122   150 
  Net cash (used for) provided by investing activities (378,875)  7,871   (113,830)  (371,004)  (94,891)
                    
CASH FLOWS FROM FINANCING ACTIVITIES:                   
Principal payments on long-term debt and capital lease obligations (674)  (107)  (719)  (781)  (807)
Excess tax benefit on equity-based compensation plans 599   10,404   -   11,003   - 
Treasury stock purchases (65,536)  (308,422)  (47,910)  (373,958)  (152,195)
Dividends paid (29,381)  (29,240)  -   (58,621)  - 
Reissuances of treasury stock related to employee stock purchase plan -   16,919   (35)  16,919   15,119 
Proceeds from issuance of common stock 4,223   4,609   8,449   8,832   21,023 
  Net cash used for financing activities (90,769)  (305,837)  (40,215)  (396,606)  (116,860)
Effect of exchange rate changes on cash (3,998)  (2,194)  1,393   (6,192)  885 
Net decrease in cash and cash equivalents (312,403)  (158,999)  (23,629)  (471,402)  (29,918)
Cash and cash equivalents at beginning of period 1,293,678   1,452,677   1,156,184   1,452,677   1,162,473 
Cash and cash equivalents at end of period$981,275  $1,293,678  $1,132,555  $981,275  $1,132,555 
                    
 

 

 
Non-GAAP Financial Summary
(in thousands, except percentages and per share data)
(unaudited)
      
 Three Months Ended Three Months Ended
 December 28, September 28,
 2014 2014
      
Revenue$1,232,241 $1,152,368
Gross margin$560,044 $528,032
Gross margin as percentage of revenue 45.4%  45.8%
Operating expenses$330,213 $321,158
Operating income$229,831 $206,874
Operating margin as a percentage of revenue 18.7%  18.0%
Net income$207,631 $167,671
Net income per diluted share$1.19 $0.96
Shares used in per share calculation -- diluted 174,316  175,433
      
 

 

  
Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income and U.S. GAAP number of dilutive shares to Non-GAAP number of dilutive shares 
(in thousands, except share and per share data) 
(unaudited) 
         
  Three Months Ended  Three Months Ended 
  December 28,  September 28, 
  2014  2014 
U.S. GAAP net income $176,940  $141,081 
Pre-tax non-GAAP items:        
 Amortization related to intangible assets acquired in Novellus transaction -- cost of goods sold  21,286   20,893 
 Costs associated with rationalization of certain product configurations -- cost of goods sold  -   1,600 
 Acquisition-related inventory fair value impact -- cost of goods sold  2,101   - 
 Amortization related to intangible assets acquired in Novellus transaction -- operating expenses  16,083   16,083 
 Restructuring charges - operating expenses  1,620   - 
 Amortization of convertible note discount, Lam notes -- other expense, net  7,682   7,593 
 Amortization of convertible note discount, Novellus assumed notes -- other expense, net  927   911 
 Net gain associated with disposition of a business -- other expense, net  -   (4,331)
Net tax (benefit) expense on non-GAAP items  (7,914)  (13,348)
Net tax benefit on valuation allowance adjustment  -   (2,811)
Net tax benefit on reinstatement of research and development credit  (11,094)  - 
Non-GAAP net income $207,631  $167,671 
Non-GAAP net income per diluted share $1.19  $0.96 
         
U.S. GAAP number of shares used for diluted per share calculation  177,046   177,118 
Effect of convertible note hedge  (2,730)  (1,685)
Non-GAAP number of shares used for diluted per share calculation  174,316   175,433 
         
 

 

  
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating Income to Non-GAAP Gross Margin, Operating Expenses and Operating Income 
(in thousands, except percentages) 
(unaudited) 
      
  Three Months Ended Three Months Ended 
  December 28, September 28, 
  2014 2014 
U.S. GAAP gross margin $ 536,657 $505,539 
Pre-tax non-GAAP items:       
 Amortization related to intangible assets acquired in Novellus transaction -- cost of goods sold  21,286  20,893 
 Costs associated with rationalization of certain product configurations -- cost of goods sold  -  1,600 
 Acquisition-related inventory fair value impact -- cost of goods sold  2,101  - 
Non-GAAP gross margin  $ 560,044 $528,032 
U.S. GAAP gross margin as a percentage of revenue  43.6%  43.9% 
Non-GAAP gross margin as a percentage of revenue  45.4%  45.8% 
U.S. GAAP operating expenses  $ 347,916 $337,241 
Pre-tax non-GAAP items:       
 Amortization related to intangible assets acquired in Novellus transaction - operating expenses  (16,083  (16,083)
 Restructuring charges -- operating expenses  (1,620  - 
Non-GAAP operating expenses  $ 330,213 $321,158 
Non-GAAP operating income  $ 229,831 $206,874 
Non-GAAP operating margin as a percent of revenue  18.7%  18.0% 
 

Lam Research Corporation Contact:

Audrey Charles
Investor Relations
Phone: 510-572-1615
E-mail: audrey.charles@lamresearch.com

Source: Lam Research Corporation

 

News Provided by Acquire Media